Almanack Investment Partners, Llc. Vertex Pharmaceuticals Inc Transaction History

Almanack Investment Partners, Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $361,646 - $482,329	-1,747 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $19,940 - $23,641	78 Added 4.67%	1,747 $376,000
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $2,705 - $3,549	12 Added 0.72%	1,669 $485,000
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $331,018 - $410,621	1,657 New	1,657 $394,000

1,726

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.